Back to Journal

SM Dermatology Journal

Umbilical Melanoma: An Entity to Approach Thoughtfully: A Literature Review And Case Series

[ ISSN : 2575-7792 ]

Abstract Citation INTRODUCTION METHODS Case series Literature search Primary outcome RESULTS Melanoma characteristics Diagnosis Therapy DISCUSSION Melanocytic naevus or melanoma? CONCLUSION DECLARATIONS REFERENCES
Details

Received: 03-Mar-2025

Accepted: 29-Apr-2025

Published: 30-Apr-2025

Decraene Brecht1*, Stas Marguerite1,2 and Boecxstaens Veerle1,2

1Department of Surgical Oncology, UZ Leuven, Belgium
2Department of Oncology, Biomedical Sciences Group, Belgium

Corresponding Author:

Brecht Decraene MD, Department of Surgical Oncology, Herestraat 49, 3000 Leuven, Belgium

Keywords

Pathophysiology; Embryological; Immunotherapy; Umbilical Melanoma

Abstract

Umbilical melanoma is an extremely rare and underreported disease with a complex underlying anatomy and the requirement for a tailored, specific approach. Embryological remnants in this region render this tumor more prone to metastatic spread via these structures. Inadequate treatment of this specific tumor can therefore result in a more devastating prognosis. This makes a more radical approach, compared to other melanoma, a necessity. Our aim is to provide an in-depth inside into the unique characteristics of this disease, the underlying anatomy and pathophysiology, and the required approach in order to be able to adequately manage this tumor. In this respect, we performed a detailed literature search for this rare disease as well as presented a case series from our tertiary center.

Citation

Brecht D, Marguerite S, Veerle B (2025) Umbilical Melanoma: An Entity to Approach Thoughtfully: A Literature Review And Case Series. SM Dermatol J 8: 6.

INTRODUCTION

Malignant melanoma is currently the most lethal form of skin cancer with 287.723 new cases reported in 2018 worldwide, and over 60.000 deaths [1].

The incidence of cutaneous melanoma varies between countries because of differences in skin phenotype and sun exposure. Overall, over the past decades its prevalence has been steadily rising in the western world [2], resulting in increased morbidity and mortality. Despite the omnipresence of these tumors, melanoma located in the umbilical area are rare and often underestimated. In literature only very few articles have been published on this topic since its first report in 1916 [3], most of them being case reports 

Because of the specific anatomy and surgery of the umbilical region, inadequate treatment can result in disease progression and potentially mortality, especially in metastatic conditions [4]. Although surgical resection is considered the first-tier treatment option of all melanomas, a more complex surgical approach is required in case of umbilical melanoma. For this, a thorough knowledge of the unique characteristics of umbilical melanoma is important for both surgical treatment and aesthetic reconstruction, as well for timely referral to specialist familiar with this pathology. An extensive review based on both single-center/ personal experience and literature search highlights the possible pitfalls and oncological limitations.

METHODS

Data was collected from case series at University Hospitals Leuven and literature search.

Case series

Prospectively collected data from all umbilical melanoma patients in the UZ Leuven database until April 2020 were reviewed. Patients were included irrespectively of disease stage, treatments received or patient age. The hospital protocol for workup of these patients included lactate dehydrogenase (LDH) levels (elevated LDH may indicate distant metastases) [5] and imaging (abdominal and lymph nodes ultrasonography). The treatment protocol was based on international guidelines for the treatment of melanoma [6]: upfront surgery after biopsy, postoperative histopathological confirmation of diagnosis and extent of resection (free cutting edges), followed by radiotherapy, chemotherapy and/ or immunotherapy based on disease stage.

Literature search

A literature search was conducted for all articles containing at least one case of umbilical melanoma. Inclusion criteria were clear description of the umbilical location or a picture of the lesion. Exclusion criteria were peri-umbilical location, doubt about the exact location or only mentioning the term umbilical melanoma without reporting details. An initial online literature search in MEDLINE was performed for potentially relevant articles from inception to April 2020 (search as performed on May 1st, 2020), using following search strategy: (“Umbilicus”[Mesh] OR Umbilic*[tiab]) AND (“Melanoma”[Mesh] OR “Melanom*”[tiab]). We further expanded our search by using the ‘related article’ function and a free-word search in Trip database, Cochrane, Embase, Dare and Cinahl. There was no journal restriction, only case reports, (systematic) reviews, datasets and observational studies were included.

The literature search yielded a total of 40 articles [7-46], while a search in the reference lists of the potentially relevant articles added another 7 articles. After reading the abstracts, 32 articles did not meet the inclusion criteria, mainly because the lesions at the umbilical site were no melanoma (Figure 1). The remaining 15 articles were selected for full-text reading. Of those, all studies were included, encompassing 22 patients.

Figure 1: Overview of study selection.

Primary outcome

Patient characteristics (including potential risk factors for umbilical melanoma), lesion specific characteristic (including anatomical, diagnostic and histological information), therapy and follow-up of the umbilical melanoma were analyzed. A summary of the collected data items that were extracted from the text and from the associated images off the included articles is available in the appendix.

RESULTS

Patient characteristics

Four patients with umbilical melanoma were identified from a total of 13550 melanomas (and 6112 patients) in the electronic medical record database (Table 1). The mean age at diagnosis was 52 years (range 17 – 71), which was comparable with average age in 22 previously described cases in literature (56 years, ranging from 30 until 83). There was an equal number of women and men, whereas in literature the men: women ratio was 5:17.

Table 1: Demographics

 

PATIENT 1

PATIENT 2

PATIENT 3

PATIENT 4

PRESENTING SYMPTOM

Routine exam

Moisty lesion

Routine exam

Bleeding

AGE

55

64

71

17

GENDER

male

female

male

female

 

 

 

 

 

TYPE OF MELANOMA

SSM

SSM

SSM

SSM

BRESLOW THICKNESS (mm)

2.5

2

3.5

2.0

METASTASES at diagnosis

yes

no

no

no

 

 

 

 

 

RESECTION TO THE PERITONEUM

No

Yes

No

Yes

SNB

No

No

No

Yes

LOCAL COMPLICATIONS

No

Infection

No

No

 

OUTCOME

Deceased due to distant recurrence (52 months after diagnosis)

 

Remission

Deceased due to distant recurrence (94 months after diagnosis)

 

Remission

Two patients presented because of a suspicious umbilical lesion (moisty or bloody), while the other two were diagnosed during routine clinical examination by the general practitioner. In literature a suspicious looking lesion is found to be the most common presenting symptom, followed by discharge, pruritus and/or and bleeding. None of our patients had any first-degree relatives with cancer, nor a personal history of melanoma. Two patients were previously treated because of another malignancy (follicular adenoma of the thyroid and an adrenal adenoma). As far as the cases in literature is concerned, familial tumors were only mentioned in 11 cases (none of them had a first or second degree relative with a melanoma, one patient had family members with breast, lung and colorectal cancer). One patient of the literature cases had a personal history of breast cancer and one of stomach cancer. None of those patients had a personal melanoma history. Personal cancer history was not available in six of these patients.

Not much was mentioned regarding risk factors for melanoma development in our patients; none of them used tanning beds. For one patient it was also known that she always used factor 50 sunscreen and was minimally exposed to sunlight. Half of the patients were regularly screened by their general practitioner for any suspicious skin lesions. One of those two also reported that she never did any form of self-examination. In literature seven cases reported regular sun burns, while nothing was written about a presence of risk factors for developing a melanoma.

Melanoma characteristics

All four patients suffered from a superficial spreading malignant melanoma with an average Breslow depth 2,51 mm (range 2,05 – 3,50 mm) and Clark depth 4 (range 3-5). An example is shown in Figure 2. None of these tumors showed perineural or lymphovascular invasion. Also, regression and ulceration were absent in all lesions. In only two cases the amount of lymphocyte invasion (one brisk and one non-brisk) and the growth phase (one vertically and one both vertically and radially) were given. For the most recent case both a picture and a description of the umbilical location were available; for all other cases we had to rely on a detailed description of the location. No mutational analysis for BRAF V600E mutations was performed. In literature both superficial spreading as well as nodular subtype are described, with an average Breslow depth 6,31 mm (range 0,86 – 40,0 mm) and Clark depth 4 (range 3 -5). Most melanomas had no ulcerations. Only for one lesion the amount of lymphocyte invasion was given (brisk). Next to a description, the umbilical location was confirmed by a picture in all but four cases.In eight cases a mutational analysis was performed with three of them having a BRAF mutation, in two patients the mutation was not specified and another three having no mutation.

Figure 2: Umbilical melanoma of one of our patients

Diagnosis

In two of our patients the initial diagnosis was delayed (up to one year) because the severity of the lesion was underestimated. This is consistent with reports in literature with average delay of 12 months (range 2 – 48 months). Reasons for this delay were underestimation of the severity of the disease, using another first-tier treatment method (cryotherapy), refusal of any treatment by the patient and incorrect diagnosis (omphalitis).

Further disease staging was dependent of the pathological severity, including ultrasound of the lymph nodes, chest x-ray, PET-CT and/or MRI of the brain. This heterogeneity is similar to what is reported in literature: in older cases combination of CT and lymphoscintigram was often used,whereas in more recent cases PET-CT and/or MRI of the brain were more frequent.

One case showed metastasis (occipital and shoulder) on diagnosis as well as two malignant inguinal lymph nodes, whereas in literature 4 cases with metastasis are described.

Therapy

All patients received primary surgery: after an initial marginal resection, all lesions were widely excised including removal of the entire umbilicus to the peritoneum (R0 resection). One patient relapsed 46 months after initial surgery. In case of malignant inguinal lymph nodes a nodal clearance was performed. In the most recent case a sentinel node biopsy (SNB) was performed. A combination of radiocolloid and blue dye with immunohistochemistry staining was used and suspicious lymph nodes were found in both left (one case) and right inguinal (two cases) region. Eventually, none of those three nodes were malignant. All cases got only one biopsy before wide excision. Postoperatively 1 local infection requiring debridement, replacement of the mesh and IV antibiotics was observed.

In literature all but one case received surgery, all resulting in resection with tumor free margins. A minority was not resected to the peritoneum, while SNB was performed in 15 patients. Sentinel nodes were found in the inguinal and axillary region. In three cases adjuvant treatment was given after surgery (nivolumab, dabrafenib+trametinib with ipilimumab afterwards, and interferon). Ultrasound guided removal was done in two cases; once to remove a lymph node and once to remove an abdominal mass. In only one case a second biopsy was necessary because the first one was inconclusive.

Two of our umbilical melanoma patients passed away because of brain and lung metastasis, respectively 52 and 94 months after their diagnosis. In literature six of the 22 patients passed away because of metastases, on average 15 months after initial diagnosis (range 10-28 months).

DISCUSSION

Profound knowledge of the complex anatomy of the umbilicus is required to adequately treat umbilical melanoma. The abdominal wall at the umbilical location is formed of the following layers (from superficial to deep): skin, fat, superficial fascia, the superficial sheath of the abdominal muscle, the rectus abdominis (or linea alba in the midline, a thick cord of connective tissue), the deep sheath of the abdominal muscle, the subperitoneal connective tissue and eventually the peritoneum [47]. At birth, the umbilicus contains three umbilical vessels that obliterate later in life (one umbilical vein and two umbilical arteries) and a remnant of the urachus. These arteries will eventually form the medial ligaments, while the urachus will form the median ligament. The remnant of the umbilical vein will form the ligamentum teres.

The lymphatic drainage of the umbilical region is complex: the skin region above the umbilicus drains into the pectoral axillary lymph nodes, whereas the skin region below drains into the superficial inguinal lymph nodes. Also, for the deeper region a subdivision is made as the region above the umbilicus drains into the parasternal lymph nodes and the region below drains via the external iliac nodes to the para-aortic nodes. In literature a sentinel node biopsy (SNB) was performed in 15 cases (of which five were positive). These nodes were mostly located in the axillar region, although the inguinal region was also affected in a few cases. In one case we also detected positive sentinel nodes, which were located bilaterally in the inguinal region. Therefore, it is recommended to undertake a meticulous examination of both inguinal and axillary regions.

Understanding this complex anatomy and embryology is a necessity to understand the importance of removal of the lesion to the peritoneum, including the overlying fascia transversalis (and the sometimes-present fascia umbilicalis which can lay in between the skin and the fascia transversalis), instead of leaving the fascia intact as in other melanomas. Spreading of the melanoma along these embryological remnants is something one should keep in mind treating melanomas in the umbilical region. Incomplete superficial resection may leave tumoral tissue on the peritoneum and facilitate recurrence and spreading of the disease.

Two of our patients had only a local incision (not preperitoneal) and died because of metastases upon recurring disease. The other two cases are in remission after 12- and 94-months follow-up. A similar pattern was observed in literature: two of the three patients with lesions that were not appropriately removed passed away because of metastatic melanoma.

Also, in this region the fascia can sometimes be absent, which implies that the umbilicus is almost directly attached to the peritoneum. Moreover, the umbilicus also represents a relatively weak point in the anterior abdominal wall. Therefore, one has to be careful when taking a deeper biopsy of lesions in this area.

Melanocytic naevus or melanoma?

One of the similarities between cases is the delay (up to 4 years) between discovery of the lesion and appropriate treatment, mostly because of an underestimation of the severity of the disease or confusion with omphalitis, an infection of the umbilicus and surrounding tissue. Therefore Song et al. recommend a careful follow-up in patients with suspected omphalitis or an umbilical nevus [37]. In case of changes such as increase in size or diabrosis on the surface a further surgical investigation should be very-low threshold to exclude infection or a Sister Mary Joseph Nodule (metastasis of abdominal or pelvic malignancy). As the majority of the cases were diagnosed by a general practitioner or a dermatologist, knowledge of the unique treatment method (extensive resection to the peritoneum) is of tremendous importance for both specialties.

One of the major limitations is the fact that only retrospective data were available. Also, the small number and heterogeneity of patients hampers the possibility to draw general conclusions. Nevertheless, our 4 patients represent the second largest case series regarding umbilical melanoma.

CONCLUSION

Umbilical melanomata represent a challenging subentity of malignant melanoma due to its unique localization. Adequate knowledge of the specific anatomy and subsequent treatment method are therefore of tremendous importance when treating these lesions. Also, timely referral of patients with umbilical melanoma is crucial to avoid more advanced stage and/or metastasis.

DECLARATIONS

Ethical Approval

Studies were conducted according to ethical guidelines (Declaration of Helsinki). The project was approved by the Ethical Commission of the University Hospitals Leuven (S65568)

REFERENCES

1. Erdei E, Torres SM. A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther. 2010; 10: 1811-1823.

2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68: 394-424.

3. Cullen TS. Embryology, anatomy, and diseases of the umbilicus: together with diseases of the urachus. (Saunders, 1916).

4. Schvartsman G, Taranto P, Glitza IC, Agarwala SS, Atkins MB, Buzaid AC, et al. Management of metastatic cutaneous melanoma: updates in clinical practice. Ther Adv Med Oncol. 2019; 11: 1758835919851663.

5. Diem S, Kasenda B, Spain L, Martin-Liberal J, Marconcini R, Gore M, et al. Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma. Br J Cancer. 2016; 114: 256-261.

6. Michielin O, Van Akkooi ACJ, Ascierto PA, Dummer R, KeilholzU. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019; 30: 1884-1901.

7. Ehring F. [Omphalolith]. Hautarzt. 1979; 30: 494-496.

8. Noguera Aguilar JF, Dolz C, Cuadrado A, Olea JM, Vilella A. Transvaginal liver resection (NOTES) combined with minilaparoscopy. Rev Esp Enfermedades Dig. 2008; 100: 411-415.

9. Kluger N. [Umbilical and periumbilical dermatoses]. Ann Dermatol Venereol. 2014; 141: 224-235

10. Navysany S, Daigeler A, Dippel E, Löser C. Bauchnabel-Rekonstruktion nach malignem Melanom. JDDG – J Ger Soc Dermatology. 2013; 11: 462-464.

11. Gartmann H. [Malignant granular cell tumor]. Hautarzt. 1977; 28: 40-44.

12. Jaime TJ, Jaime TJ, Ormiga P, Leal F, Nogueira OM, Rodrigues N. Endometriose umbilical: Relato de um caso e seus achados dermatoscópicos. An Bras Dermatol. 2013; 88: 121-124.

13. Mahdi HR, El Hennawy HM. Omphalolith presented with peritonitis: A case report. Cases J. 2009; 2: 8191.

14. Brinca A, Teixeira V, Gonçalo M, Tellechea O. A large pigmented lesion mimicking malignant melanoma. Clin Exp Dermatol. 2012; 37: 817-818.

15. Cecchi R, Pavesi M, Buralli L, Rapicano V, De Gaudio C. Primary umbilical melanoma. Australas J Dermatol. 2009; 50; 220-222.

16. Vincent J, Taube JM. Letter: Pigmented extramammary Paget disease of the abdomen: A potential mimicker of melanoma. Dermato Online J. 2011; 17: 13.

17. Meine JG, Bailin PL. Primary Melanoma of the Umbilicus: Report of a Case and Review of the Relevant Anatomy. Dermato Surg. 2003; 29: 405-407.

18. Mangas C, Romaní J, Muñoz C, Luelmo J. Navel melanoma: Not always easy to detect, not always difficult to remove. Dermatol Online J. 2008; 14: 20.

19. Dessy LA, Maruccia M, Romanzi A, Onesti MG. Melanoma of the umbilicus: An incidental diagnosis during fat-harvesting donor-site selection. Aesthetic Plas Surg. 2013; 37: 489-490.

20. GRAEV M. [First known case of primary malignant melanoma of the umbilicus]. Arch De Vecchi Anat Patol. 1957; 27: 589–602.

21. DURAY PH, LIVOLSI VA. Recurrent Dysplastic Nevus Following Shave Excision. J Dermatol Surg Oncol. 1984; 10: 811-815.

22. Lassus P, De Leo A, Moussa IH, Lindford A. Paraumbilical perforator flap for reconstruction of the external auditory meatus: A case report. Microsurgery. 2015; 35: 573-575.

23. Kim HS, Jang WI, Hong HS, Lee CI, Lee DK, Yong SJ. et al. Metastatic involvement of the stomach secondary to lung carcinoma. J Korean Med Sci. 1993; 8: 24-29.

24. Campos-Muñoz L, Quesada-Cortés A, Ruiz E, Casado M, Pizarro A. Primary melanoma of the umbilicus appearing as omphalitis [3]. Cli and Exp Dermatol vol. 2007; 32: 322-323.

25. Charles KB, Chan MP, Smith NR, Orsini AP, Noh IK, Kozlow JH, et al. Primary Cutaneous Umbilical Melanoma: The Michigan Experience. Dermatol Surg. 2020; 46: 312-318.

26. De Giorgi V, Massi D, Mannone F, Stante M, Carli P. Cutaneous endometriosis: Non-invasive analysis by epiluminescence microscopy. Clin Exp Dermatol. 2003; 28: 315-317.

27. Reynolds HM, Dunbar PR, Uren RF, Thompson JF, Smith NP. Mapping melanoma lymphoscintigraphy data onto a 3D anatomically based model. Ann Biomed Eng. 2007; 35: 1444-1457.

28. Mason AR, Mohr MR, Koch LH, Hood A.F. Nevi of special sites. Clin Lab Med. 2011; 31: 229-242.

29. Colonna MR, Giovannini UM, Sturniolo G, Colonna U. The umbilicus: A rare site for melanoma. Clinical considerations in two cases. Scand. J Plast Reconstr Surg Hand Surg. 1999; 33: 449-452.

30. Suzuki S, Yoshida Y, Shiomi T, Yanagihara S, Kimura R, Yamamoto O. Melanoma of the umbilicus: A patient report, precaution in operative strategy, and the first histopathological review of published cases. Yonago Acta Med. 2016; 59: 183-187.

31. Kovitwanichkanont T, Joseph S, Yip L. Hidden in plain sight: umbilical melanoma. Med J Aust. 2020; 212: 154-155.e1.

32. Hashiro M, Miyamoto T, Sonoda S, Okumura M. Malignant melanoma developing from an intradermal nevus. Dermatol. 1998; 196: 425-426.

33. Monroe JR, PA-C MPAS. Umbilical lesion appears in a woman with a history of sun exposure. JAAPA. 2006; 19: 60.

34. Dutta SK, Costa BS. Umbilicated Gastric Polyposis: An Indicator of Metastatic.Gastric Tumor. Am J Gastroenterol. 1979; 71: 598-604.

35. Ramirez P, Sendagorta E, Feito M, Gonzalez-Beato M, Mayor M, Pizarro A. Letter: Umbilical basal cell carcinoma in a 21-year-old man: Report of an exceptional case and dermatoscopic evaluation. Dermatol Online J. 2011; 17: 16.

36. Fernandez D. Cryopreserved amniotic membrane and umbilical cord for a radiation-induced wound with exposed dura: A case report. J Wound Care. 2019; 28: S4-S8.

37. Song Y, Xu D, Sun L, Ding K, Hu Y, Yuan YB. Diagnosis and management of primary umbilical melanoma with omphalitis features. Case Rep in Oncol. 2013; 6: 154-157.

38. Tatu AL. Umbilicated blue-black lesion on the lateral thorax. J Cutan Med Surg. 2017; 21: 252.

39. Di Monta G, Caracò C, Marone U, Grimaldi AM, Anniciello AM, Di Marzo M, et al. Clinicopathologic features and surgical management of primary umbilical melanoma: A case series. BMC Res Notes. 2015; 8: 147.

40. Stoltz JF, Bensoussan D, Decot V, Ciree A, Netter P, Gillet P. Cell and tissue engineering and clinical applications: An overview. Biomed Mater Eng. 2006; 16: S3-S18.

41. Flux K, Hartschuh W. Congenital spindle cell naevus with unusual transformation: Proliferative nodule or melanoma? Acta Derm Venereol. 2012; 92: 152-155.

42. Alabed YZ, Sakellis C. Umbilical plugoma mimics melanoma metastasis on FDG PET/CT. Clin Nucl Med. 2015; 40: 812-813.

43. Zaccagna A, Siatis D, Pisacane A, Giacone E, Picciotto F. Surgical treatment of primary melanoma of the umbilicus with sentinel lymph node biopsy and plastic reconstruction: Case report and review of the literature. Eur J Surg Oncol. 2011; 37: 233-236.

44. Mason AR, Mohr MR, Koch LH, Hood AF. Nevi of Special Sites. Surg Pathol Clin. 2009; 2: 471-481.

45. Miller MJ, Balch CM. Iris technique for immediate umbilical reconstruction. Plast Reconstr Surg. 1993; 92: 754-756.

46. Xin SC, Zhao YQ, Li S, Lin S, Zhong HB. [Application of zebrafish models in drug screening]. Yi Chuan. 2012; 34: 1144-1152.

47. Fahmy M, Fahmy M. Anatomy and Physiology of the Umbilicus. in Umbilicus and Umbilical Cord 97–100 (Springer International Publishing, 2018).

Other Articles

Article Image 1

Melanoma Incidence Yesterday and Today - Where are we Going?

Skin cancer is the most common cancer in the United States of America, including melanoma and non-melanoma skin cancer. Malignant melanoma, being ranked as the fifth most common cancer within the US shows a yearly incidence of 73,870 cases and remains the most aggressive form of all skin cancers with a mortality rate of 2.7 per 100,000 [1,2]. Fortunately, over the last decade melanoma treatment options have tremendously improved. Progress in areas such as immunotherapy and targeted therapies has lead to increased melanoma survival rates, rising from 82% (1975-1977) to 93% (2004-2010) [3]. In consequence, the cost of skin cancer treatments, specifically for melanoma treatments increased from an average annual total cost of $864 million in 2002 to $3349 million in 2011 [4].

Yusuke Suita and Elisabeth M Roider*


Article Image 1

Targeted Molecular Therapies for Non-Melanoma Skin Cancer

Non-melanoma skin cancer (NMSC) is the most common cancer among Caucasian populations worldwide. More than 1 million new NMSCs are diagnosed each year, making it the most common cancer in the United States. Basal cell carcinomas (BCCs) account for about 80% of NMSCs, and most of the remainder are squamous cell carcinomas (SCCs) [1]. The treatment of advanced-stage NMSCs is challenging as surgical excision becomes impossible. Recent advances in the treatment of these tumors include targeted molecular therapies against epidermal growth factor receptor (EGFR) and hedgehog signaling pathway.

Nataliya Lutay*


Article Image 1

Nevus Spilus: A Review of the Literature

Nevus spilus (NS) is usually the term given to a pigmented skin lesion, either congenital or acquired, consisting of a large light tan patch, containing macules or papules. Usually, these superimposed lesions are numerous, small circumscribed, dark brown in color, flat or slightly raised. Nevus spilus can be seen anywhere on the body surface, but the most common location is on the chest and upper limbs. NS was first described by Burkley in 1842 as evenly pigmented patches and Ito and Hamado in 1952 were the first to apply the term NS to speckled lesions. For a long time, NS was believed to be a benign lesion. However, more than one case of melanoma arising in NS has been published. As a rule, NS is not considered a precursor of melanoma, but to this day, despite the wide range of publications, it is still necessary to clarify the relationship between NS and melanoma, in terms of the risk factors of turning malignant. We will describe the clinical features, the evolution and the management of NS, in view also of the recent genetic findings.

Maria Teresa Corradin1 , Veronica Cacitti2 , Erika Giulioni1 , Maria Martina Patriarca1 , Angelo Vettorello3


Article Image 1

A Woman with Hyperpigmentation of the Forehead

A 32-year-old woman presented with asymptomatic hyperpigmentation of her forehead cosmetically concerning to the patient. It worsened during summer months and lessened during the winter. It has been present for five years. Her medical history was significant for ADD managed with stimulants. She has been on the same estrogen/progesterone combination oral contraceptive for ten years. Physical examination revealed a tan, macular rash on forehead without raised borders or scale. Urine HCG was negative.

Jason Ramirez1*


Article Image 1

Lichen Simplex Chronicus: Easy Psychological Interventions that Every Dermatologist Should Know

Lichen Simplex Chronicus (LSC) is a chronic skin disease characterized by lichenified plaques, which occur as result of constant scratching or rubbing of skin. Pruritus is the predominant symptom that leads to the development of LSC. Frequent pruritus triggers include mechanical irritation, environmental factors, such as heat and sweating, and psychological factors, such as stress and anxiety.

From a psychodermatology point of view, the interruption of the never-ending itch-scratch cycle, which characterizes LSC, is of supreme importance for patient’s recovery. Furthermore, emotional tensions, as seen in patients with anxiety, depression, or obsessive-compulsive disorder, may play a key role in inducing a pruritic sensation, leading to scratching that can become self-perpetuating.

Referral to a psychiatrist or a psychotherapist might be required in many cases. However, this referral could be difficult in daily practice, given the patient’s unwillingness to seek mental health counseling. Therefore, the dermatologist should focus and be able to perform, at least at a very basic level, some easy psychological interventions that would help patients to end with the itch-scratch cycle, while helping the patients to accept the need to seek for mental help.

In this article, we describe easy cognitive behavioral techniques to address the factors that exacerbate and maintain itch-scratch cycle in LSQ patients. Moreover, we stress in the need that dermatologists should be trained in the usage of these techniques in order to help LSQ patients, especially when referral to a psychiatrist is hindered because of the patients’ reluctance of seeking mental help.

Julio Torales1*, Iván Barrios2 , Liz Lezcano3 and Beatriz Di Martino4


Article Image 1

Polymethyl Methacrylate Microspheres in the Treatment of Facial Rejuvenation: A Large Retrospective Series

Study Background: Soft tissue temporary and semi-permanent fillers continue to increase in popularity worldwide for facial rejuvenation. The study aims to review the cosmetic use and complication rate in large retrospective case series of Polymethyl Methacrylate (PMMA) microspheres in facial rejuvenation.

Methods: The study is a retrospective case series of 779 patients that underwent PMMA filler by one senior provider (NM) for facial rejuvenation to 7 consistent and reproducible areas of the face determined from chart review in order of preference: Peri-oral (589), Infra-orbital (395), Nasolabial folds (379), Temporal (212), Cheek (161), Glabella (99), and Scar area (8) from February 2009 to September 2015 and the chart review was completed in May 2016.

Results: The average age at first injection was 51.4 years old with standard deviation of 12.2 years. Seven hundred and six patients were female and 73 were male. Forty-three (5.4%) patients injected with PMMA had nodular complications. The average time to first sign of complication was 1.2 years with a range of .02 to 4.61 years. Prior blepharoplasty, rhytidectomy, rhinoplasty, Fitzpatrick skin classification, or history of autoimmunity was not significant to nodular complication. Thirty-four patients resolved with multiple steroid injections averaging 3.7 injections to resolution. Five were lost to follow up. Four have had ongoing injections with one undergoing surgical resection for multiple infra-orbital and peri-oral nodules.

Conclusions: Injection of permanent PMMA filler using a subdermal technique in the context of facial rejuvenation is possible with clinically significant cosmetic benefit. Since this is an off-label use of PMMA filler, caution must be taken with full disclosure to the patient leading to informed consent.

Nasrin Mani1*, Majid Mani2 , Daniel N Sauder2 and Marcella R Bothwell3


Article Image 1

Sclerodermatous Skin: An Immunohistochemical Study

Objective: Systemic Sclerosis (SSc) is primarily characterized by autoimmunity, microangiopathy, and tissue fibrosis. Hypoxia, a powerful stimulator of Vascular Endothelial Growth Factor (VEGF), may be responsible for excessive expression of chronic VEGF in SSc. The oxygen-regulated α-subunit of HypoxiaInducible Transcription Factor-1 (HIF-1α) plays an important role in transcriptional regulation of VEGF. The protein phosphatase and tensin homolog (PTEN) is responsible for dephosphorylation of proteins and thereby promotes tissue repair.

The present study aimed to examine the expressions of HIF-1α, PTEN, and VEGF in patients with scleroderma in an attempt to estimate prognosis and guide therapeutic decisions. We therefore studied the expressions of HIF-1α, VEGF, and PTEN in skin samples exhibiting the features of scleroderma.

Methods: Skin biopsies of patients were obtained and samples were stained with primary antibodies following PTEN, VEGF and HIF-1α, immunohistochemically.

Results: The SSc and the control group were compared with respect to staining of epidermal keratinocytes, fibroblasts, and the endothelial cells for the antibodies. SSc patients displayed a reduced VEGF expression in endothelial cells. The lesion group showed a significantly lower staining of epidermal cells and endothelial cells for PTEN. SSc group was also characterized by a significantly weaker HIF-1α expression compared to the control group.

Conclusion: In scleroderma skin samples, manipulated expression of these molecules at varying stages of the disease may affect the prognosis of scleroderma.

Rabia Bozdogan Arpaci1*, Tuba Kara1 , Yasemin Yuyucu Karabulut1 , Didar Gursoy1 , Yalçın Polat2 , Gulhan Orekici3 and Umit Tursen4


Article Image 1

Role of Erythroid Differentiation Regulator 1 (Erdr1) On Inflammatory Skin Disorders: A Review

Inflammatory skin diseases remain as one of the most common problems in dermatology. Skin inflammation is a complex process that starts with the introduction of a stimulus such as an allergen or an antigen that triggers the skin to produce inflammatory substances called cytokines and chemokines. At present, the approved drugs for treating inflammatory skin conditions are corticosteroids, yet these can have negative side effects on the skin. Erythroid Differentiation Regulator 1 (Erdr1) is a cytokine previously thought to be connected with hemoglobin synthesis only but was recently found to be involved in inflammation. This review examined the role of Erdr1 as a therapeutic target in the treatment of inflammatory skin disorders. By reviewing previous studies, it was evident that Erdr1 has pro-apoptotic activities; it is able to induce apoptosis in melanoma cells by the regulation of factors such as Bcl-2 and Bax. Treatment with Recombinant Erdr1 (r Erdr1) was also able to inhibit rosacea by inhibiting blood vessel growth or angiogenesis and preventing further infiltration of inflammatory cells. There was also significant reduction of erythema, inflammatory cell infiltration, and microvessel density with Vascular Endothelial Growth Factor (VEGF). Altogether, these studies suggest that Erdr1 has a therapeutic effect on inflammatory skin diseases, particularly psoriasis, rosacea and other skin disorders.

Saad Sami AlSogair*


Article Image 1

Efficacy of Lasers on Vascular Lesions and Rejuvenation

Our purpose is to study the efficacy of the NdYAG Laser (1064 nm) when treating telangiectasias and hemangiomas, and the efficacy of the NdYAG Laser and fractional laser on rejuvenation. We used data from our private office from the past five years (2011-2015). We also studied the side effects of the therapies. We treated 500 patients with telangiectasias and 300 patients with hemangiomas with NdYAG Laser. As far as telangiectasias were concerned, the results were much better when the face was treated. In contrast, the recurrence rates were much higher when the legs were treated. The results were impressive in almost all cases of cherry hemangiomas. The combination of NdYAG Lasers and fractional lasers on a monthly basis had satisfactory results in rejuvenation.

Maria Voyatzi*1 , Julia Grammatikopoulou1 , Eleni Karlafti2 , Androniki Mavroudi1 ,

Foteini Lamprou1 , Genovefa Kypri1 , Theodosia Gkentsidi1 and Maria Tsirmigka1


Article Image 1

Refining Techniques in Eyebrow Transplantation

There has been a growing demand for facial hair restoration including eyebrow hair transplantation. The demand for non-scalp hair restoration is reflective of the cultural trends where full eyebrows are in vogue. Our clinic has seen a large increase in non-scalp hair restoration. Given the large experience allowed by our patient population, we have been able to refine our techniques for optimal results in eyebrow restoration. Presented in this article are our techniques developed from over 1,000 eyebrow transplantations.

Anthony Bared* and Jeffrey S. Epstein